Reduced holdings in Sarepta Therapeutics by Bank Julius Bär & Co. Ltd. Zurich, and significant stock transactions by directors
A well-known institutional investor, Bank Julius Baer & Co. Ltd Zurich, has reduced its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) by a massive 73.2% during the second quarter of this year. After selling 2,855 shares during the quarter, Bank Julius Baer & Co. Ltd Zurich now just owns 1,044 shares of Sarepta Therapeutics stock, according … Read more